1-(2-羟乙基)-4-甲基哌嗪，CAS 登记号 5464-12-0，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1-(2-羟乙基)-4-甲基哌嗪 的 CAS 号：5464-12-0，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1-(2-hydroxyethyl)-4-methylpiperazine · CAS 5464-12-0 · C7H16N2O.
| CAS Registry Number | 5464-12-0 |
|---|---|
| PubChem CID | 231184 |
| Molecular formula | C7H16N2O |
| IUPAC name | 2-(4-methylpiperazin-1-yl)ethanol |
| Molecular Weight | 144.21 |
|---|---|
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 144.126263138 |
| Monoisotopic Mass | 144.126263138 |
| Topological Polar Surface Area | 26.7 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (12.5%), H312 (12.5%), H315 (87.5%), H318 (12.5%), H319 (75%), H332 (12.5%), H335 (62.5%) |
|---|
H302 (12.5%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (12.5%): Harmful in contact with skin [Warning Acute toxicity, dermal]
1-(2-Hydroxyethyl)-4-methylpiperazine; DTXSID10282618; RefChem:422252; DTXCID00233770; 673-560-2; 5464-12-0; 2-(4-methylpiperazin-1-yl)ethanol; 1-piperazineethanol, 4-methyl-; MFCD03840691; 2-(4-methylpiperazin-1-yl)ethan-1-ol; 2-(4-Methyl-1-piperazinyl)ethanol; 4-Methylpiperazine-1-ethanol; 2-(4-methyl-piperazin-1-yl)-ethanol; SCHEMBL8753; 2-(4-methyl-1-piperazinyl) ethanol; 2-(4-methyl-piperazin-1yl)-ethanol
CAS 5464-12-0; molecular formula C7H16N2O; molecular weight — g/mol.
1-(2-Hydroxyethyl)-4-methylpiperazine, DTXSID10282618, RefChem:422252, DTXCID00233770, 673-560-2, 5464-12-0.
Hazard statements reported: H302, H312, H315, H318, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.